STK33
Basic information
Region (hg38): 11:8391868-8594289
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spermatogenic failure 93 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Genitourinary | 34155512 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the STK33 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 33 | 36 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 33 | 4 | 0 |
Variants in STK33
This is a list of pathogenic ClinVar variants found in the STK33 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-8392529-C-G | not specified | Uncertain significance (Aug 16, 2021) | ||
11-8392539-C-T | not specified | Uncertain significance (Nov 29, 2023) | ||
11-8392592-G-T | not specified | Uncertain significance (Jul 09, 2021) | ||
11-8392647-T-C | not specified | Uncertain significance (Mar 04, 2024) | ||
11-8392657-C-G | not specified | Uncertain significance (Jun 29, 2022) | ||
11-8392667-T-C | not specified | Uncertain significance (Dec 12, 2023) | ||
11-8413533-C-G | not specified | Uncertain significance (Sep 26, 2023) | ||
11-8413553-T-G | not specified | Conflicting classifications of pathogenicity (Jul 01, 2022) | ||
11-8413583-G-A | not specified | Uncertain significance (Aug 21, 2023) | ||
11-8413583-G-C | not specified | Uncertain significance (Jan 11, 2023) | ||
11-8413601-G-A | not specified | Uncertain significance (Dec 26, 2023) | ||
11-8413603-TG-T | Spermatogenic failure 93 | Pathogenic (Oct 25, 2024) | ||
11-8413610-T-C | not specified | Uncertain significance (Aug 09, 2021) | ||
11-8413616-A-T | not specified | Likely benign (Feb 28, 2024) | ||
11-8413628-T-C | not specified | Uncertain significance (Aug 02, 2021) | ||
11-8435535-T-C | not specified | Uncertain significance (Jun 13, 2022) | ||
11-8435544-G-C | not specified | Uncertain significance (Dec 03, 2021) | ||
11-8436118-A-C | Neoplasm of the pancreas | Likely pathogenic (May 13, 2016) | ||
11-8436125-G-A | not specified | Uncertain significance (Mar 24, 2023) | ||
11-8440691-C-T | not specified | Likely benign (Sep 01, 2021) | ||
11-8440728-G-C | not specified | Uncertain significance (Mar 07, 2023) | ||
11-8452887-G-A | not specified | Uncertain significance (Apr 01, 2024) | ||
11-8452889-T-G | not specified | Uncertain significance (Feb 05, 2024) | ||
11-8454746-T-G | not specified | Uncertain significance (Mar 01, 2024) | ||
11-8454778-A-G | not specified | Likely benign (Mar 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
STK33 | protein_coding | protein_coding | ENST00000447869 | 12 | 202419 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000217 | 0.977 | 125708 | 0 | 39 | 125747 | 0.000155 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.490 | 233 | 255 | 0.914 | 0.0000123 | 3393 |
Missense in Polyphen | 45 | 65.922 | 0.68262 | 897 | ||
Synonymous | -1.18 | 104 | 89.8 | 1.16 | 0.00000484 | 900 |
Loss of Function | 2.09 | 13 | 24.1 | 0.540 | 0.00000111 | 332 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000216 | 0.000216 |
Ashkenazi Jewish | 0.000105 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000945 | 0.0000924 |
European (Non-Finnish) | 0.000182 | 0.000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000358 | 0.000294 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Serine/threonine protein kinase which phosphorylates VIME. May play a specific role in the dynamic behavior of the intermediate filament cytoskeleton by phosphorylation of VIME (By similarity). Not essential for the survival of KRAS-dependent AML cell lines. {ECO:0000250, ECO:0000269|PubMed:21742770}.;
Recessive Scores
- pRec
- 0.0835
Intolerance Scores
- loftool
- 0.878
- rvis_EVS
- -0.07
- rvis_percentile_EVS
- 48.69
Haploinsufficiency Scores
- pHI
- 0.140
- hipred
- N
- hipred_score
- 0.243
- ghis
- 0.509
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.616
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Stk33
- Phenotype
Gene ontology
- Biological process
- signal transduction in response to DNA damage;mitotic DNA damage checkpoint;protein autophosphorylation
- Cellular component
- nucleus;cytoplasm;perinuclear region of cytoplasm
- Molecular function
- protein serine/threonine kinase activity;ATP binding